Keyphrases
Electroconvulsive Therapy
100%
Cognitive Effects
100%
Erythropoietin
100%
Add-on Treatment
100%
Randomized Controlled Trial
100%
Therapy Session
27%
Saline Injection
27%
Functional Magnetic Resonance Imaging
27%
Treatment Strategy
18%
Structural Magnetic Resonance Imaging (sMRI)
18%
Severe Depression
18%
Current Treatment
9%
Therapy Treatment
9%
Etiology
9%
Erythropoietin Therapy
9%
Blood Biomarkers
9%
Cognitive Benefits
9%
Biomarker Data
9%
Treatment Completion
9%
Neural Underpinnings
9%
Randomized Placebo-controlled Trial
9%
Primary Outcome Measure
9%
Parallel Group Design
9%
Beneficial Effects
9%
Repeated Measures Analysis
9%
Neuroplasticity
9%
Bipolar Disorder
9%
Executive Function
9%
Protective Effect
9%
Randomized Trial
9%
Analysis of Covariance
9%
Implications for Future
9%
Cognitive Dysfunction
9%
Placebo
9%
Speed Function
9%
Change from Baseline
9%
Neural Substrates
9%
A-level
9%
High Dose
9%
Clinically Significant
9%
Novel Treatments
9%
Psychomotor Speed
9%
Between-group Difference
9%
Effective Treatment
9%
Unipolar Disorder
9%
Method Design
9%
Oxidative Stress Markers
9%
Inflammation
9%
Moderate to Severe
9%
Neuroscience
Electroconvulsive Therapy
100%
Erythropoietin
100%
Randomized Controlled Trial
100%
Functional Magnetic Resonance Imaging
27%
Severe Depression
18%
Placebo
18%
Cognitive Disorder
9%
Neuroplasticity
9%
Executive Function
9%
Bipolar Disorder
9%
Major Depressive Disorder
9%
Oxidative Stress
9%